Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with tacrolimus
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kessler M et al. | A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus. | 1999 | Transplantation | pmid:10071045 |
Jain AB et al. | Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil. | 1999 | Liver Transpl Surg | pmid:10071348 |
Jain AB et al. | Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events. | 1999 | Liver Transpl Surg | pmid:10071354 |
Mitsumoto Y et al. | FK506 with portal decompression exerts beneficial effects following extended hepatectomy in dogs. | 1999 | Eur Surg Res | pmid:10072610 |
Jain A et al. | Immunosuppressive therapy. | 1999 | Surg. Clin. North Am. | pmid:10073182 |
Reyes J and Mazariegos GV | Pediatric transplantation. | 1999 | Surg. Clin. North Am. | pmid:10073188 |
Sigalet DL et al. | Effect of combined immunosuppressive drug therapy on small intestinal nutrient transport in the rat. | 1999 | Clin. Biochem. | pmid:10074892 |
Trajković V et al. | Cyclosporin A suppresses the induction of nitric oxide synthesis in interferon-gamma-treated L929 fibroblasts. | 1999 | Scand. J. Immunol. | pmid:10075015 |
Jordan ML et al. | Long-term results of pancreas transplantation under tacrolius immunosuppression. | 1999 | Transplantation | pmid:10075592 |
Shapiro R et al. | Pediatric renal transplantation under tacrolimus-based immunosuppression. | 1999 | Transplantation | pmid:10075598 |